The Multiple Myeloma Daily
A selection of articles, blog posts, videos and photos recommended by Robert Z. Orlowski
A selection of articles, blog posts, videos and photos recommended by Robert Z. Orlowski
Immunoglobulin light chain (AL) amyloidosis is characterized by the deposition of misfolded monoclonal free light chains, with cardiac complications accounting for patients’ mortality. Clonal hematopoiesis…
Myeloma Paper of the Day, April 25th, suggested by Robert Orlowski / cancer, MajesTEC-1 trial, MD Anderson Cancer Center, multiple myeloma, Myeloma, Myeloma
Myeloma Paper of the Day, April 22nd, suggested by Robert Orlowski / BRAF mutations, cancer, KRAS mutation, MD Anderson Cancer Cente, monoclonal plasma cell
Myeloma Paper of the Day, April 21st, suggested by Robert Orlowski / BCMA CAR-T cell therapy, cancer, CD19 CAR-T cells, MD Anderson Cancer Center, multiple
Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium
Map of Myeloma_Doc X (Twitter) followers.
A physician who has worked with unmatched applicants explains how to make the most of the coming year and improve the odds of matching in…
Map of Myeloma_Doc X (Twitter) followers.
This study on anti-MAG neuropathy provides updated insights into the epidemiology of this disease, clinical profiles, and treatment approaches in Japan. Rituximab therapy, used for…
Gain/amplification of 1q21 (≥3 copies), a chromosomal abnormality frequently observed in multiple myeloma, can negatively affect prognosis, due to its involvement in resistance to anti-myeloma…